Silverfin false false 28/02/2025 01/03/2024 28/02/2025 J Edgely 02/03/2020 L Lamont 02/03/2020 06 October 2025 The principal activity of the Company during the financial year was that of pharmacy retail. SC565810 2025-02-28 SC565810 bus:Director1 2025-02-28 SC565810 bus:Director2 2025-02-28 SC565810 2024-02-29 SC565810 core:CurrentFinancialInstruments 2025-02-28 SC565810 core:CurrentFinancialInstruments 2024-02-29 SC565810 core:Non-currentFinancialInstruments 2025-02-28 SC565810 core:Non-currentFinancialInstruments 2024-02-29 SC565810 core:ShareCapital 2025-02-28 SC565810 core:ShareCapital 2024-02-29 SC565810 core:SharePremium 2025-02-28 SC565810 core:SharePremium 2024-02-29 SC565810 core:RetainedEarningsAccumulatedLosses 2025-02-28 SC565810 core:RetainedEarningsAccumulatedLosses 2024-02-29 SC565810 core:Goodwill 2024-02-29 SC565810 core:Goodwill 2025-02-28 SC565810 core:PlantMachinery 2024-02-29 SC565810 core:Vehicles 2024-02-29 SC565810 core:FurnitureFittings 2024-02-29 SC565810 core:ComputerEquipment 2024-02-29 SC565810 core:PlantMachinery 2025-02-28 SC565810 core:Vehicles 2025-02-28 SC565810 core:FurnitureFittings 2025-02-28 SC565810 core:ComputerEquipment 2025-02-28 SC565810 core:MoreThanFiveYears 2025-02-28 SC565810 core:MoreThanFiveYears 2024-02-29 SC565810 2023-02-28 SC565810 bus:OrdinaryShareClass1 2025-02-28 SC565810 2024-03-01 2025-02-28 SC565810 bus:FilletedAccounts 2024-03-01 2025-02-28 SC565810 bus:SmallEntities 2024-03-01 2025-02-28 SC565810 bus:AuditExemptWithAccountantsReport 2024-03-01 2025-02-28 SC565810 bus:PrivateLimitedCompanyLtd 2024-03-01 2025-02-28 SC565810 bus:Director1 2024-03-01 2025-02-28 SC565810 bus:Director2 2024-03-01 2025-02-28 SC565810 core:Goodwill core:TopRangeValue 2024-03-01 2025-02-28 SC565810 core:PlantMachinery core:TopRangeValue 2024-03-01 2025-02-28 SC565810 core:Vehicles core:TopRangeValue 2024-03-01 2025-02-28 SC565810 core:FurnitureFittings 2024-03-01 2025-02-28 SC565810 core:ComputerEquipment core:TopRangeValue 2024-03-01 2025-02-28 SC565810 2023-03-01 2024-02-29 SC565810 core:Goodwill 2024-03-01 2025-02-28 SC565810 core:PlantMachinery 2024-03-01 2025-02-28 SC565810 core:Vehicles 2024-03-01 2025-02-28 SC565810 core:ComputerEquipment 2024-03-01 2025-02-28 SC565810 bus:OrdinaryShareClass1 2024-03-01 2025-02-28 SC565810 bus:OrdinaryShareClass1 2023-03-01 2024-02-29 SC565810 1 2024-03-01 2025-02-28 iso4217:GBP xbrli:pure xbrli:shares

Company No: SC565810 (Scotland)

ROSLIN HEALTH CARE LIMITED

UNAUDITED FINANCIAL STATEMENTS
FOR THE FINANCIAL YEAR ENDED 28 FEBRUARY 2025
PAGES FOR FILING WITH THE REGISTRAR

ROSLIN HEALTH CARE LIMITED

UNAUDITED FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 28 FEBRUARY 2025

Contents

ROSLIN HEALTH CARE LIMITED

BALANCE SHEET

AS AT 28 FEBRUARY 2025
ROSLIN HEALTH CARE LIMITED

BALANCE SHEET (continued)

AS AT 28 FEBRUARY 2025
Note 2025 2024
£ £
Fixed assets
Intangible assets 3 670,133 724,358
Tangible assets 4 42,237 34,848
712,370 759,206
Current assets
Stocks 63,989 67,807
Debtors 5 2,830,597 2,965,474
Cash at bank and in hand 201,218 320,663
3,095,804 3,353,944
Creditors: amounts falling due within one year 6 ( 752,781) ( 819,066)
Net current assets 2,343,023 2,534,878
Total assets less current liabilities 3,055,393 3,294,084
Creditors: amounts falling due after more than one year 7 ( 1,403,307) ( 1,658,576)
Provision for liabilities 8 ( 3,653) ( 6,348)
Net assets 1,648,433 1,629,160
Capital and reserves
Called-up share capital 9 100 100
Share premium account 1,179,072 1,179,072
Profit and loss account 469,261 449,988
Total shareholder's funds 1,648,433 1,629,160

For the financial year ending 28 February 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Roslin Health Care Limited (registered number: SC565810) were approved and authorised for issue by the Board of Directors on 06 October 2025. They were signed on its behalf by:

J Edgely
Director
ROSLIN HEALTH CARE LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 28 FEBRUARY 2025
ROSLIN HEALTH CARE LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 28 FEBRUARY 2025
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Roslin Health Care Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in Scotland. The address of the Company's registered office is Roslin Pharmacy , 122 Penicuik Road, Roslin, EH25 9NT, Scotland, United Kingdom.

The financial statements have been prepared under the historical cost convention and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The directors have assessed the Balance Sheet and likely future cash flows at the date of approving these financial statements. The directors have a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Turnover

Turnover from pharmacy sales is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT.

Employee benefits

Short term benefits
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised as an expense when the Company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

Defined contribution schemes
Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.

Deferred tax
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's financial statements. Deferred tax is provided in full on timing differences which result in an obligation to pay more or less tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Deferred tax assets and liabilities are not discounted.

Intangible assets

Intangible assets are stated at cost or valuation, net of amortisation and any provision for impairment. Amortisation is provided on all intangible assets at rates to write off the cost or valuation of each asset over its expected useful life as follows:

Goodwill 20 years straight line
Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Plant and machinery 4 years straight line
Vehicles 3 years straight line
Fixtures and fittings 20 % reducing balance
Computer equipment 3 years straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Leases

The Company as lessee
Assets held under finance leases, hire purchase contracts and other similar arrangements, which confer rights and obligations similar to those attached to owned assets, are capitalised as tangible fixed assets at the fair value of the leased asset (or, if lower, the present value of the minimum lease payments as determined at the inception of the lease) and are depreciated over the shorter of the lease terms and their useful lives. The capital elements of future lease obligations are recorded as liabilities, while the interest elements are charged to the Profit and Loss Account over the period of the leases to produce a constant periodic rate of interest on the remaining balance of the liability.

Rentals under operating leases are charged on a straight-line basis over the lease term, even if the payments are not made on such a basis. Benefits received and receivable as an incentive to sign an operating lease are similarly spread on a straight-line basis over the lease term.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Profit and Loss Account.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

Stocks held for distribution at no or nominal consideration are measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stock over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand and deposits held at call with banks.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Basic financial liabilities
Basic financial liabilities, including creditors and bank loans, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Government grants

Government grants are recognised based on the performance model and are measured at the fair value of the asset received or receivable when there is reasonable assurance that the company will comply with conditions attaching to them and the grants will be received.

Government grants relating to turnover are recognised as income over the periods when the related costs are incurred.

Provisions

Provisions are recognised when the Company has a present obligation (legal or constructive) as a result of a past event, it is probable that the Company will be required to settle that obligation and a reliable estimate can be made of the amount of the obligation.

The amount recognised as a provision is the best estimate of the consideration required to settle the present obligation at the Balance Sheet date, taking into account the risks and uncertainties surrounding the obligation. Where a provision is measured using the cash flows estimated to settle the present obligation, its carrying amount is the present value of those cash flows (when the effect of the time value of money is material).

When some or all of the economic benefits required to settle a provision are expected to be recovered from a third party, a receivable is recognised as an asset if it is virtually certain that reimbursement will be received and the amount of the receivable can be measured reliably.

2. Employees

2025 2024
Number Number
Monthly average number of persons employed by the Company during the year, including directors 21 18

3. Intangible assets

Goodwill Total
£ £
Cost
At 01 March 2024 1,084,506 1,084,506
At 28 February 2025 1,084,506 1,084,506
Accumulated amortisation
At 01 March 2024 360,148 360,148
Charge for the financial year 54,225 54,225
At 28 February 2025 414,373 414,373
Net book value
At 28 February 2025 670,133 670,133
At 29 February 2024 724,358 724,358

4. Tangible assets

Plant and machinery Vehicles Fixtures and fittings Computer equipment Total
£ £ £ £ £
Cost
At 01 March 2024 97,992 29,983 99,756 640 228,371
Additions 0 24,337 0 0 24,337
Disposals 0 ( 22,983) 0 0 ( 22,983)
At 28 February 2025 97,992 31,337 99,756 640 229,725
Accumulated depreciation
At 01 March 2024 97,992 27,650 67,241 640 193,523
Charge for the financial year 0 10,445 6,503 0 16,948
Disposals 0 ( 22,983) 0 0 ( 22,983)
At 28 February 2025 97,992 15,112 73,744 640 187,488
Net book value
At 28 February 2025 0 16,225 26,012 0 42,237
At 29 February 2024 0 2,333 32,515 0 34,848

5. Debtors

2025 2024
£ £
Trade debtors 193,194 208,469
Amounts owed by Group undertakings 2,601,269 2,716,501
Other debtors 36,134 40,504
2,830,597 2,965,474

6. Creditors: amounts falling due within one year

2025 2024
£ £
Trade creditors 321,871 321,124
Taxation and social security 69,502 97,043
Other creditors 361,408 400,899
752,781 819,066

7. Creditors: amounts falling due after more than one year

2025 2024
£ £
Other creditors 1,403,307 1,658,576

Amounts repayable after more than 5 years are included in creditors falling due over one year:

2025 2024
£ £
Other creditors 373,694 628,963

8. Deferred tax

2025 2024
£ £
At the beginning of financial year ( 6,348) ( 8,705)
Credited to the Profit and Loss Account 2,695 2,357
At the end of financial year ( 3,653) ( 6,348)

9. Called-up share capital

2025 2024
£ £
Allotted, called-up and fully-paid
100 Ordinary shares of £ 1.00 each 100 100

10. Related party transactions

Transactions with entities in which the entity itself has a participating interest

2025 2024
£ £
Amounts due from related parties 2,601,269 2,728,501

Other related party transactions

2025 2024
£ £
Amounts due to key management personnel 53,204 97,448

11. Ultimate controlling party

The company's immediate parent entity is L & M Lamont Limited, a company registered in Scotland (SC653810). In the Directors' opinion, J Edgely is the ultimate controlling party by virtue of her shareholding in the parent entity.